Selected article for: "amino acid and CoV polymerase"

Author: Minchen Chien; Thomas K. Anderson; Steffen Jockusch; Chuanjuan Tao; Shiv Kumar; Xiaoxu Li; James J. Russo; Robert Kirchdoerfer; Jingyue Ju
Title: Nucleotide Analogues as Inhibitors of SARS-CoV-2 Polymerase
  • Document date: 2020_3_20
  • ID: 8prn86g6_4
    Snippet: Given the 98% amino acid similarity of the SARS-CoV and SARS-CoV-2 RdRps, 10 we reasoned that the four nucleotide analogues listed in Fig. 1 would also inhibit the SARS-CoV-2 polymerase. We thus assessed the ability of 2'-F,Me-UTP, 3'-F-dTTP, TFV-DP, and 3'-N 3 -dTTP (the active triphosphate forms of Sofosbuvir, Alovudine, TAF and AZT, respectively), to be incorporated by SARS-CoV-2 RdRp into an RNA primer and terminate the polymerase reaction......
    Document: Given the 98% amino acid similarity of the SARS-CoV and SARS-CoV-2 RdRps, 10 we reasoned that the four nucleotide analogues listed in Fig. 1 would also inhibit the SARS-CoV-2 polymerase. We thus assessed the ability of 2'-F,Me-UTP, 3'-F-dTTP, TFV-DP, and 3'-N 3 -dTTP (the active triphosphate forms of Sofosbuvir, Alovudine, TAF and AZT, respectively), to be incorporated by SARS-CoV-2 RdRp into an RNA primer and terminate the polymerase reaction.

    Search related documents:
    Co phrase search for related documents
    • ability assess and polymerase reaction: 1, 2, 3, 4
    • amino acid and nucleotide analogue: 1, 2
    • amino acid and polymerase reaction: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • amino acid and polymerase reaction terminate: 1
    • amino acid and RNA primer: 1, 2, 3, 4, 5, 6, 7
    • amino acid and SARS polymerase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • amino acid and SARS polymerase inhibit: 1
    • amino acid and SARS RdRp incorporate: 1
    • amino acid and triphosphate form: 1, 2, 3
    • amino acid similarity and nucleotide analogue: 1
    • amino acid similarity and polymerase reaction: 1, 2, 3, 4, 5, 6
    • amino acid similarity and RNA primer: 1
    • amino acid similarity and SARS polymerase: 1, 2, 3
    • amino acid similarity and SARS polymerase inhibit: 1
    • amino acid similarity and triphosphate form: 1, 2
    • nucleotide analogue and polymerase reaction: 1, 2, 3
    • nucleotide analogue and RNA primer: 1, 2, 3
    • nucleotide analogue and SARS polymerase: 1, 2, 3, 4, 5, 6, 7, 8
    • nucleotide analogue and SARS polymerase inhibit: 1, 2